Remove Extraction Remove Patients Remove Supply Chain
article thumbnail

Cannabis on the Ballot, November 4: Florida, Nebraska, the Dakotas

Canna Law Blog

These new laws would: a) strip out penalties for qualified patients in possession of five ounces or less of medical marijuana, and b) create a Nebraska Medical Cannabis Commission to regulate and license the supply chain. Will Nebraska’s Measures pass? opposing; and 4.6% undecided.

article thumbnail

Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil

Cannabis Law Report

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement. About Avicanna.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Cannabis Law Report

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union.

article thumbnail

UK’s Grow Group, medical cannabis startup, acquires Spain’s Sanoid, major cannabis producer

Cannabis Law Report

This transaction will enable the firm to deliver further on its mission of providing the broadest portfolio of quality cannabis medicines to patients across the world at the most accessible prices.

article thumbnail

Why a SARs-CoV-2 qPCR Assay for Cannabis is Necessary

Medicinal Genomics

If last summer’s vape scare taught us anything, it’s that politicians will pull the plug on the cannabis supply chain if it is believed to be a vector for COVID-19 transmission. We then inoculated Gamma irradiated SARs-CoV-2 virus into hemp flower and extracted and quantitated with qPCR across 7 days.

article thumbnail

Curaleaf International Launches Second Medical Cannabis Flower Product for UK Market

Cannabis Law Report

250% Increase in Patient Numbers Since Initial Launch of Flower Products in March 2021. Curaleaf International’s vertically integrated business model, comprising cultivation, extraction, production and distribution, has been designed so that high quality medical cannabis flower is consistently accessible and affordable for UK patients.

article thumbnail

LeafCann CEO, Elisabetta Faenza, elected to CIC Board and Chair of Standards Group

Cannabis Law Report

Patient access. I’ve been working hard with some great advocates for patient access in the UK and this position will give me the opportunity to ensure that patients will have access to the high-quality medicines and products they deserve.”.